Advert: 100729EuroCMELeaderboard
line
Menu top
Menu bottom
Website and Archive search
  Go
JobSearch
  Go
  Advert: 100729EuroCMEMPU
MAGAZINE AUDIT BY
ABC Logo
Where am I? > Home > Industry News > World News
Hline
Advert: 160x600px-Gold-Wide-Skyscraper
LATEST WORLD NEWS Rss Feed    
Solid results for Amgen but all eyes on denosumab
Amgen’s adjusted net income for the second quarter has edged up 1% to $1.33 billion, while turnover was up 2% to $3.80 billion

 Merck KGaA earnings shoot up, profit forecast raised
Merck KGaA has posted a strong set of figures for the second quarter this morning, which reveal that earnings jumped 70.1%

 Wellcome Trust and India team up for affordable drugs
The Wellcome Trust has extended its alliance with the Government of India’s Department of Biotechnology, this time setting up a £45 million partnership to develop “innovative healthcare products at affordable costs”

 		GSK pays out $15 million to option Anacor antibiotic
GlaxoSmithKline has exercised its option to develop an antibiotic from Anacor Pharmaceuticals which has shown potential in early-stage studies

 NiCox still optimistic after naproxcinod failure in USA
Fresh from having its pain product naproxcinod rejected by the FDA, NicOx has posted its financial results for the first six months of 2010 which show that the French biotech is still in a reasonable state, cashwise

 Strong quarter for AstraZeneca as FDA panel backs Brilinta
AstraZeneca shares are on the rise this morning after the firm posted a strong set of financials for the second quarter and celebrated a recommendation for approval from US advisory panel for its bloodthinner Brilinta
More Headlines
Arrow Solid results at Sanofi, plays down Genzyme bid
Arrow Bayer pharma earnings fall as R&D spend climbs
Arrow Servier could be hit with hefty fine for ‘misleading’ EU
Arrow FDA gives priority to Merck KGaA's MS pill
Arrow US patients “should have EU-approved drugs”
Arrow UK lags Europe in uptake of new cancer drugs, study shows
Arrow £50M more for cancer drugs in England from October to April
Arrow Teva earnings soar yet again, driven by Copaxone
Arrow Merck & Co signs China vaccines alliance
Arrow Sanofi looks to block generic Lovenox in court
Arrow FDA staffers pretty positive on AstraZeneca's Brilinta
Arrow GSK revamps system for paying sales reps

Older >
 
Join PharmaTimes Directors Club
Arrow Find out more
PharmaTimes Club for Directors Secretaries
Arrow Learn more
LATEST JOBS
Arrow   Junior Editor, Healthcare Communications
Arrow   Hospital Specialist - Northern & Western Home Counties
Arrow   PRODUCT MANAGER - HOMECARE
Arrow   Part-time Medical Representative
Arrow   Medical Scientific Liaison Representative
Arrow   Regional Account Manager/Business Manager
Arrow   Territory Manger- North-West
Arrow   GP/Hospital Representative
Arrow   Product and Promotions Manager - Aesthetics
Arrow   Consulting careers in International Life-Sciences Executive Search
line
flickrtwitteryoutube